Vanda Pharmaceuticals Inc. (LON:0LKB)

Vanda Pharmaceuticals Statistics

Total Valuation

LON:0LKB has a market cap or net worth of GBP 243.50 million. The enterprise value is 7.87 million.

Market Cap	243.50M
Enterprise Value	7.87M

Important Dates

The next estimated earnings date is Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	59.09M
Shares Outstanding	n/a
Shares Change (YoY)	+1.34%
Shares Change (QoQ)	+0.80%
Owned by Insiders (%)	5.14%
Owned by Institutions (%)	65.80%
Float	49.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.64
PB Ratio	0.69
P/TBV Ratio	0.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.16
EV / Sales	0.05
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.16

Financial Position

The company has a current ratio of 3.25, with a Debt / Equity ratio of 0.02.

Current Ratio	3.25
Quick Ratio	3.05
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.18
Interest Coverage	-52.37

Financial Efficiency

Return on equity (ROE) is -13.01% and return on invested capital (ROIC) is -12.01%.

Return on Equity (ROE)	-13.01%
Return on Assets (ROA)	-9.87%
Return on Invested Capital (ROIC)	-12.01%
Return on Capital Employed (ROCE)	-20.03%
Revenue Per Employee	403,561
Profits Per Employee	-132,764
Employee Count	368
Asset Turnover	0.32
Inventory Turnover	6.27

Taxes

Income Tax	-13.18M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.59% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+12.59%
50-Day Moving Average	4.87
200-Day Moving Average	4.62
Relative Strength Index (RSI)	61.79
Average Volume (20 Days)	2,314

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.37

Income Statement

In the last 12 months, LON:0LKB had revenue of GBP 148.51 million and -48.86 million in losses. Loss per share was -0.83.

Revenue	148.51M
Gross Profit	140.19M
Operating Income	-73.58M
Pretax Income	-62.04M
Net Income	-48.86M
EBITDA	-67.79M
EBIT	-73.58M
Loss Per Share	-0.83

Balance Sheet

The company has 237.62 million in cash and 8.49 million in debt, giving a net cash position of 229.12 million.

Cash & Cash Equivalents	237.62M
Total Debt	8.49M
Net Cash	229.12M
Net Cash Per Share	n/a
Equity (Book Value)	354.97M
Book Value Per Share	6.01
Working Capital	199.58M

Cash Flow

In the last 12 months, operating cash flow was -47.30 million and capital expenditures -810,189, giving a free cash flow of -48.11 million.

Operating Cash Flow	-47.30M
Capital Expenditures	-810,189
Free Cash Flow	-48.11M
FCF Per Share	n/a

Margins

Gross margin is 94.40%, with operating and profit margins of -49.55% and -32.90%.

Gross Margin	94.40%
Operating Margin	-49.55%
Pretax Margin	-41.77%
Profit Margin	-32.90%
EBITDA Margin	-45.64%
EBIT Margin	-49.55%
FCF Margin	n/a

Dividends & Yields

LON:0LKB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.34%
Shareholder Yield	-1.34%
Earnings Yield	-20.06%
FCF Yield	-19.76%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0LKB has an Altman Z-Score of 1.02 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.02
Piotroski F-Score	3